SanaClis returns to Clinical Operations Strategy Meeting 2017

Bratislava, Slovakia: –Full service, award-winning CRO SanaClis will once again participate in the Clinical Operations Strategy Meeting in Boston, Massachusetts, as a sponsor and exhibitor.

This is a return appearance at the Clinical Operations Strategy meeting for SanaClis, which has attended the event consistently since 2015.

Full service CRO

“As a full-service provider, we define this event as the right place for establishing closer relationships with potential business partners and tracing of pharma trends as it is one of the largest events that gathers global network of professionals involved in clinical trials,” commented Alexander Fetkovsky, Managing Partner and Board Member, who represents SanaClis at the event along with Managing Director Roman Hrynchuk.

SanaClis will use the meeting to highlight its impressive IMP/CTS management capabilities.

IMP Management

“We understand that IMP management is a core factor in successful clinical trials. Therefore, we would like to also showcase own software dedicated to IMP management that enables clients to have direct access to IMP stock and movements in warehouses.

“Participants will be able to try out the online tracking of IMP storage conditions for themselves,” said Mr. Fetkovsky.

The display will also feature a wide range of promotional materials, including pens and USB sticks carrying multimedia company presentations.

Cost-quality solutions

“Reaching out to pharma and biotech decision makers within clinical operations, clinical development, supply chain and data management, we will be showing best possible “cost-quality” solutions that leverage from our own resources, facilities and partnership synergies,” Alexander Fetkovsky explained.

“We can also help open the door to the EU for non-EU companies as well as, working the other way, opening up opportunities to deliver high-quality clinical trials in countries in Central and Eastern Europe, known for data quality, site productivity and low cost-per-patient. As an addition, or an alternative to meanwhile frequently utilized countries in the core central Europe we also offer clinical trial services (including in-house IMP management) in Russia, Ukraine, Belarus, and Georgia,” he added.

About SanaClis

SanaClis is a Slovakian-headquartered full service European CRO supporting pharma and biotech companies for more than 15 years covering full cycle of Phase I-IV clinical trials under one roof. In addition to classical CRO services such as regulatory, clinical monitoring and project management, data management and biostatistics it also offers IMP management services in Central and Eastern Europe via its network of GxP-compliant warehouses.

In 2012, SanaClis s.r.o. was rated positively by reputable business agency Creditreform and for 2013, 2014, 2015, 2016 was certified with the AA rating “High creditworthiness” by Bisnode rating agency. SanaClis has earned its place on Nice Insight’s survey of Top Ten lists of Clinical Research Organizations (CROs) for 2015, based on customer perceptions of quality.

SanaClis’ Founder and Chair of the Board, Dr. Natalia Fetkovska, joined the ranks of the winners of BW’s annual CEO Awards 2016 in recognition for her work in taking SanaClis to become leading CRO in Central and Eastern Europe, recognizes for its reliability and professionalism.

This is the first time a Slovakian-headquartered CRO has finished among the leaders in CRO industry, reflecting intensive investments and quality assurance measures. In 2015, SanaClis was awarded with the CRO Leadership Award in the category Reliability. Moreover in 2015 SanaClis was awarded for Excellence in Drug Development – Europe & Best for Clinical Trials 2015. In 2016, SanaClis was rewarded with Award for Best Drug Development CRO 2016 – Europe & Award for Excellence in Clinical Trial Monitoring – Europe. Afterwards SanaClis was recognized by CV magazine and received Health Tech & Pharma Innovation Awards 2016 in the category Software.

About Clinical Operations Strategy Meeting 2017

The Clinical Operations Roundtable Discussions Strategy Meeting is an annual gathering of more than 100 C-Level Directors representing emerging to large Pharmaceutical, Biotechnology & Academic/Research Institutions to help solve key strategic challenges in Clinical Operations.

The meeting reaches out to thought leaders and leaders from the worlds of clinical operations, data sciences, clinical outsourcing, patient recruitment, eTMF, safety data management, clinical trial management, data acquisition technology and integrations, clinical, pharmacology scientific operations, clinical informatics and innovation.

The 2017 Clinical Operations Strategy Meeting is a one-day event, held November 8, at the Westin Waterfront Hotel in Boston, Massachusetts.

The event is organized by Proventa International, with more information at: https://proventainternational.com/clinical-operations-usa-ec-2017/#discussions